ML-007C-MA for Acute Schizophrenia Symptoms

ML-007C-MA for Acute Schizophrenia Symptoms
53%42%31%May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 28May 27 • YES 42.0%
MapLight Therapeutics ($MPLT)
No stock close$30.30$28.14$25.98May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 28May 18 • MPLT $26.50May 19 • MPLT $27.08May 20 • MPLT $27.81May 21 • MPLT $29.28May 22 • MPLT $28.75May 26 • MPLT $29.46May 27 • MPLT $29.55May 28 • MPLT $29.78

Will this trial show a positive result on change From Baseline to End of Treatment in Positive and Negative Syndrome Scale (PANSS) Total Score?

Paper Trading
Create account to trade
ClinicalNewsTrialPositionsReasoningOracle
Scientific editorial illustration for Schizophrenia

Schizophrenia

Schizophrenia is a serious mental illness that can cause hallucinations, delusions, disorganized thinking, and reduced motivation. Lower PANSS symptom scores can mean clearer thinking, fewer frightening experiences, and better daily functioning.

1Worldwide Prevalence: ~23 million people2U.S. Prevalence Range: 0.25%–0.64%3Life Expectancy Gap: 9 years earlier